Strand Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 28.10 Cr
- Paid Up Capital ₹ 23.47 Cr
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 35.02 Cr
- Revenue Growth -14.65%
- Profit Growth -77.06%
- Ebitda -43.32%
- Net Worth 16.19%
- Total Assets 9.39%
About Strand Life Sciences
Strand Life Sciences Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 October 2000 and has a history of 24 years and four months. Its registered office is in Bengaluru, Karnataka, India.
The Corporate was formerly known as Strand Genomics Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 28.10 Cr and a paid-up capital of Rs 23.47 Cr.
The company has closed loans amounting to ₹35.02 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Strand Life Sciences Private Limited India are Ramesh Hariharan as Ceo, Anand Janakiraman as Cfo, and Wazda Tarannum as Company Secretary. Siddharth Achuthan, Vijaya Chandru, Nikhil Kavipurapu, and Three other members serve as directors at the Company.
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85199KA2000PTC027913
- Company No.
027913
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2000
- Date of AGM
29 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Strand Life Sciences Private Limited offer?
Strand Life Sciences Private Limited offers a wide range of products and services, including Computer and Mobile Softwares & Apps, Data Management Systems, Data Entry & Data Processing Service, Database Management, Graphic Design & Animation Services, Graphic Design Services, Analyzers & Analytical Instruments, Digital Analyzers.
Who are the key members and board of directors at Strand Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Hariharan | CEO | 13-Apr-2022 | Current |
| Anand Janakiraman | CFO | 20-Jul-2022 | Current |
| Wazda Tarannum | Company Secretary | 11-Sep-2023 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Chandru  | Director | 23-Oct-2000 | Current |
| Ramesh Hariharan | Director | 01-Oct-2011 | Current |
| Nilesh Modi | Director | 07-Jan-2022 | Current |
| Siddharth Achuthan | Director | 19-Feb-2022 | Current |
| Nikhil Kavipurapu | Director | 07-Jan-2022 | Current |
| Rahul Dutt | Director | 19-Jan-2022 | Current |
Financial Performance of Strand Life Sciences.
Strand Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.65% decrease. The company also saw a substantial fall in profitability, with a 77.06% decrease in profit. The company's net worth Soared by an impressive increase of 16.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strand Life Sciences?
In 2023, Strand Life Sciences had a promoter holding of 88.83% and a public holding of 11.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V - Retail LimitedNikhil Kavipurapu is a mutual person
Science Gallery BengaluruVijaya Chandru is a mutual person
Sterling And Wilson Renewable Energy LimitedRahul Dutt is a mutual person
Aaidea Solutions LimitedNikhil Kavipurapu is a mutual person
Balkrishna Industries LimitedRahul Dutt is a mutual person
Actoserba Active Wholesale LimitedNikhil Kavipurapu is a mutual person
Charges (Loans)
₹0
₹35.02 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 18.00 Cr
- Kotak Mahindra Bank Limited : 5.00 Cr
- Technology Development Baord : 4.60 Cr
- Hdfc Bank Limited : 3.00 Cr
- Others : 2.25 Cr
- Others : 2.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2018 | Yes Bank Limited | ₹18.00 Cr | Satisfied |
| 18 Apr 2017 | Others | ₹2.25 Cr | Satisfied |
| 06 Aug 2014 | Kotak Mahindra Bank Limited | ₹5.00 Cr | Satisfied |
| 27 May 2011 | Department Of Biotechnology (Ministry Of Science And Technology) | ₹2.17 Cr | Satisfied |
| 01 Dec 2009 | Hdfc Bank Limited | ₹3.00 Cr | Satisfied |
How Many Employees Work at Strand Life Sciences?
Strand Life Sciences has a workforce of 428 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strand Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strand Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
